HSCS (HeartSciences Inc. Common Stock) Stock Analysis - SEC Filings

HeartSciences Inc. Common Stock (HSCS) is a publicly traded Healthcare sector company. As of May 21, 2026, HSCS trades at $1.89 with a market cap of $5.92M and a P/E ratio of -0.40. HSCS moved +0.00% today. Year to date, HSCS is -37.34%; over the trailing twelve months it is -57.02%. Its 52-week range spans $1.77 to $6.47. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces HSCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find HSCS SEC filings?

Rallies organizes HSCS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

HSCS Key Metrics

Key financial metrics for HSCS
MetricValue
Price$1.89
Market Cap$5.92M
P/E Ratio-0.40
EPS$-4.61
Dividend Yield0.00%
52-Week High$6.47
52-Week Low$1.77
Volume162
Avg Volume0
Revenue (TTM)$8.67K
Net Income$-8.49M
Gross Margin57.92%

Latest HSCS News

Recent HSCS Insider Trades

  • HILZ MARK T sold 4.42K (~$15.62K) on Jul 29, 2025.

HSCS Analyst Consensus

2 analysts cover HSCS: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.

Common questions about HSCS

Where can I find HSCS SEC filings?
Rallies organizes HSCS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show HSCS 10-K and 10-Q filings?
Rallies organizes HSCS SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is HSCS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HSCS. It does not provide personalized investment advice.
HSCS

HSCS